Publication | Closed Access
TP53 and P21 polymorphisms: Response to cisplatinum/paclitaxel-based chemotherapy in ovarian cancer
50
Citations
45
References
2005
Year
P21 PolymorphismsMedicineGynecologyCancer TreatmentCancer GeneticsCisplatinum/paclitaxel-based ChemotherapyOncologyRadiation OncologyEndocrine-related CancerOvarian Cancer
| Year | Citations | |
|---|---|---|
Page 1
Page 1